International Clinical Trial: Prospective, multi-center, first in human (FIH) study of the Shockwave Medical Fizz Fizz Peripheral System for the treatment of atherosclerotic, stenotic peripheral arteries

Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ACTRN12625001158459) titled 'Prospective, multi-center, first in human (FIH) study of the Shockwave Medical Fizz Fizz Peripheral System for the treatment of atherosclerotic, stenotic peripheral arteries' on Oct. 22.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group Type of endpoint: Safety/efficacy

Primary Sponsor: Shockwave Medical

Condition: Peripheral Artery Disease Peripheral Artery Disease Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

Intervention: The Shockwave Fizz Fizz Peripheral ...